• Academy
    • Find lectures, courses & contributors
    • Webinars on-demand
    • Online courses
    • 89th EAS Congress, Helsinki 2021
  • Publications
  • Become an EAS member
    Sign in
    • Academy
      • Webinars on-demand
      • Online courses
      • 89th EAS Congress, Helsinki 2021
    • Publications
    • Become an EAS member
    • Sign in

    Origin/Event: EAS AC in Lipidology

    Plasma lipoproteins and their role in atherogenesis

    PCSK9 inhibitor therapy – The cure for atherosclerosis?

    PCSK9 Inhibition – HIGHLIGHTS FROM RECENT PUBLICATIONS

    PCSK9 – From promise to clinical practice

    Panel discussion

    Lipid lowering therapies – statins

    Lipid guidelines, where we stand?

    Introduction to the course

    HDL, non HDL cholesterol and TG – a role in atherosclerosis?

    Genetics for the identification of therapeutic targets in dyslipidaemia

    Load More

    Recent Posts

    • ASCVD and Lp(a) assessment survey among clinicians
    • EAS Annual Members’ General Assembly
    • Gene-based therapies. The next generation of Atherosclerosis treatment
    • EAS Lipid Clinic Network

    Recent Comments

      © 2022 - EAS Digital

      Report

      Contains abusive or derogatory content
      Contains mature or sensitive content
      Contains misleading or false information
      Contains spam, fake content or potential malware
      Harassment or bullying behavior

      Block Member?

      Please confirm you want to block this member.

      You will no longer be able to:

      • See blocked member's posts
      • Mention this member in posts
      • Invite this member to groups
      • Message this member
      • Add this member as a connection

      Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

      Report

      You have already reported this